Lenz Therapeutics, Inc. · NASDAQ:LENZ

Paradigm Biocapital Advisors LP's stake in Lenz Therapeutics, Inc. fell to 3.80% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Paradigm Biocapital Advisors LP's stake in Lenz Therapeutics, Inc. fell to 3.80%, 1,073,461 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
3.80%
Shares
1,073,461
Intent
Passive
What changed
Fell below 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP3.80%1,073,461
Paradigm BioCapital Advisors GP LLC3.80%1,073,461
Senai Asefaw, M.D.3.80%1,073,461
Paradigm BioCapital International Fund Ltd.3.30%946,447

Source

View original at SEC

Related